Financial Results
Search documents
Bank of Hawai‘i Corporation Fourth Quarter 2025 and Full Year 2025 Financial Results
Businesswire· 2026-01-26 11:45
HONOLULU--(BUSINESS WIRE)--Bank of Hawai'i Corporation (NYSE: BOH) (the "Company†) today reported diluted earnings per common share of $4.63 for the full year of 2025, compared with $3.46 for the full year of 2024. Net income for the year was $205.9 million, up 37.3% from the previous year. The return on average common equity for the full year of 2025 was 13.29% compared with 10.85% in 2024. Diluted earnings per common share was $1.39 for the fourth quarter of 2025, compared with $1.20 during t. ...
BIOQUAL Presents Unaudited Financial Results for Second Quarter of Fiscal Year 2026
Businesswire· 2026-01-22 17:37
Core Insights - BIOQUAL, Inc. reported a revenue of $20,834,840 for the six months ended November 30, 2025, which represents a decrease from $23,165,920 in the same period of 2024 [1] - The company experienced a loss before income tax of $532,917 for the six months ended November 30, 2025, compared to a loss of $2,604,227 in the prior year [1] - The net loss for the six months ended November 30, 2025, was $386,117, significantly improved from a net loss of $1,887,527 in the same period of 2024 [1] - Basic earnings per share of common stock improved to $(0.43) for the six months ended November 30, 2025, compared to $(2.11) for the same period in 2024 [1] Financial Performance - Revenue for the three months ended November 30, 2025, was $10,979,441, down from $11,395,438 in the same quarter of 2024 [1] - Loss before income tax for the three months ended November 30, 2025, was $(189,485), an improvement from $(1,672,402) in the same quarter of 2024 [1] - The net loss for the three months ended November 30, 2025, was $(137,285), compared to $(1,212,202) in the same quarter of 2024 [1] - Basic earnings per share for the three months ended November 30, 2025, was $(0.15), an improvement from $(1.36) in the same quarter of 2024 [1]
Tesla Q4 and full year 2025 Financial Results and Q&A Webcast
Tesla· 2026-01-22 00:40
To submit a question: https://app.saytechnologies.com/tesla-2025-q4 ...
Gibraltar Announces Preliminary Fourth Quarter and 2025 Results
Businesswire· 2026-01-21 12:30
Core Viewpoint - Gibraltar Industries, Inc. reported preliminary estimated unaudited consolidated financial results for Q4 and the year ended December 31, 2025, indicating a decline in net sales and operating income compared to previous guidance and 2024 results [1]. Financial Results Summary - **Q4 2025 Estimates**: - Net Sales: $261 - $271 million, down from previous guidance of $283 - $308 million and 2024's $232 million [1] - Operating Income: $13 - $15 million, significantly lower than previous guidance of $33 - $37 million and 2024's $26 million [1] - Adjusted Operating Income: $27 - $29 million, compared to previous guidance of $41 - $45 million [1] - Adjusted EBITDA: $35 - $37 million, down from previous guidance of $48 - $53 million [1] - GAAP EPS: $0.36 - $0.41, lower than previous guidance of $0.82 - $1.73 [1] - Adjusted EPS: $0.72 - $0.77, compared to previous guidance of $1.04 - $1.14 [1] - **Full Year 2025 Estimates**: - Net Sales: $1,128 - $1,138 million, down from previous guidance of $1,150 - $1,175 million and 2024's $1,023 million [1] - Operating Income: $121 - $123 million, lower than previous guidance of $141 - $145 million [1] - Adjusted Operating Income: $149 - $151 million, compared to previous guidance of $163 - $167 million [1] - Adjusted EBITDA: $184 - $186 million, down from previous guidance of $197 - $202 million [1] - GAAP EPS: $3.21 - $3.26, lower than previous guidance of $3.67 - $4.58 [1] - Adjusted EPS: $3.88 - $3.93, compared to previous guidance of $4.20 - $4.30 [1] Segment Performance - **Residential Segment**: The building accessories business showed participation gains, helping to offset volume declines in end markets. Adjustments in channel inventory are believed to align better with customer demand entering 2026 [4]. - **Agtech Segment**: Large project volumes shifted out of 2025, but bookings and backlog more than tripled from the previous year, indicating strong future potential [4]. - **Infrastructure Segment**: Revenue growth was noted with strong margin performance, contributing positively to overall results [4]. Strategic Outlook - The company anticipates that price increases and cost reduction initiatives implemented in Q4 will benefit results in 2026. There is confidence in the momentum of the building accessories segment and the expected acquisition of Omnimax, which is on track to close in Q1 2026 [1][4]. - The company enters 2026 with a strong backlog in Agtech, solid performance in Infrastructure, and over $115 million in cash, indicating a robust financial position [1].
Rockwell Medical Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Financial Results
Businesswire· 2026-01-20 11:00
Core Insights - Rockwell Medical, Inc. reported significant revenue growth and improved financial metrics for Q4 and full-year 2025, indicating a strong operational performance and a focus on profitability [2][7] - The company achieved a gross margin of 22% in Q4 2025, a notable increase from 14% in Q3 2025, reflecting enhanced operational efficiencies and cost reductions [2][7] - Rockwell Medical aims to focus on revenue growth, increased profitability, and portfolio diversification as key strategic areas for 2026 [2] Financial Highlights - Preliminary net sales for Q4 2025 are expected to be approximately $18.6 million, while full-year 2025 net sales are projected at around $69.5 million [7] - Cash flow from operations for Q4 2025 is anticipated to be approximately $2.3 million, marking the second cash flow positive quarter in 2025 [7] - Cash and cash equivalents, along with investments available-for-sale, are expected to increase to approximately $25 million by December 31, 2025 [7] Company Overview - Rockwell Medical specializes in developing, manufacturing, and distributing hemodialysis products for dialysis providers globally, with a mission to deliver high-quality products and exceptional customer service [5] - The company is recognized as a Great Place to Work for three consecutive years (2023, 2024, 2025) and has been named among Fortune's Best Workplaces in Manufacturing & Production for 2024 and 2025 [5] - Rockwell Medical is committed to innovative growth strategies that enhance its product offerings and operational processes, aiming to provide significant value to the healthcare system and improve the lives of hemodialysis patients [5]
ETC Announces Fiscal 2026 Third Quarter Results
Globenewswire· 2026-01-13 14:00
SOUTHAMPTON, Pa., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID: ETCC) (“ETC” or the “Company”) today reported its financial results for the thirteen week period ended November 28, 2025 (the “2026 fiscal third quarter”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “Sales declined in the third fiscal quarter as we have been executing against several large contracts, which are in the final phase of completion. However, we are pleased with the 12% ...
Optex Systems Holdings, Inc. Announces Financial Highlights for the Year Ended September 28, 2025
Accessnewswire· 2025-12-17 14:00
Core Viewpoint - Optex Systems Holdings, Inc. reported its financial results for the year ending September 28, 2025, highlighting significant developments in the company and its market position [1]. Financial Performance - The company has shown growth in its financial metrics, reflecting a strong performance in the precision optical sighting systems sector for military and commercial applications [1]. - CEO Danny Schoening expressed optimism about the company's progress and achievements over the past year, indicating a positive outlook for future operations [1].
2026 Financial Calendar of EfTEN Real Estate Fund AS
Globenewswire· 2025-12-15 06:00
Core Points - EfTEN Real Estate Fund AS has scheduled the publication of its financial results and the annual general meeting of shareholders for 2026 [1] Financial Results Schedule - The company plans to release unaudited results for Q4 2025 and the full year 2025 on January 29, 2026 [1] - Audited results for the year 2025 will be published on February 27, 2026 [1] - The annual general meeting is set for April 7, 2026 [1] - Interim results for Q1 will be available on April 30, 2026 [1] - Q2 interim results are scheduled for July 30, 2026 [1] - Q3 interim results will be published on October 29, 2026 [1]
Parks! America, Inc. Reports Fourth Quarter and Full Year Fiscal Year 2025 Financial Results
Globenewswire· 2025-12-12 21:10
Management to host conference call on Monday, December 15, 2025, at 4:30 PM ET PINE MOUNTAIN, Georgia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Parks! America, Inc. (OTCQX: PRKA), today announced its financial results for the fourth fiscal quarter and fiscal year ended September 28, 2025. The summary information in this press release should not be used as the sole basis for making investment decisions. We encourage shareholders to read our complete Form 10-K, which has been posted on the Investor Info section of t ...
Donaldson Posts Upbeat Results, Joins Science Applications International, Descartes Systems, Dollar General And Other Big Stocks Moving Higher On Thursday - ASP Isotopes (NASDAQ:ASPI), Bioage Labs (NA
Benzinga· 2025-12-04 15:12
Core Insights - U.S. stocks experienced a decline, with the Dow Jones falling approximately 0.1% on Thursday [1] - Donaldson Company, Inc. saw a significant increase in its stock price following positive quarterly results [1] Financial Performance - Donaldson's sales increased by 3.9% year over year to $935.4 million, surpassing the consensus estimate of $922.9 million, driven by favorable currency translation and volume growth [2] - GAAP net earnings rose to $113.9 million (97 cents per share) from $99.0 million (81 cents per share) in the previous year [2] - The company reported adjusted EPS of 94 cents, exceeding the consensus of 92 cents [2] - Donaldson raised its fiscal 2026 guidance for adjusted EPS to a range of $3.95-$4.11, compared to the previous range of $3.92-$4.08 and the consensus of $4.01 [2] Stock Performance - Donaldson shares increased by 4.7% to $91.78 on Thursday [3] - Other notable stock performances included UiPath Inc. with a 16.5% increase, Science Applications International Corporation with a 15.8% rise, and Dollar General Corporation with a 9% gain following better-than-expected financial results [5]